ZCA1 SRB-5 (A1); june 6-7, 2019; DR. Jennifer schiltz; bethesda north marriott hotel & conference center; total hotel cost complies with HHS policy on promoting efficient spending as of 1/3/2012

Ended Awarded Last action

Contract number
75N91019F00136
Awardee
Awarding agency
Obligated
$14,799

Award facts

Contract value 100% obligated
$14,798.54 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
North Bethesda, MD 20852, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · To DE-obligate funds from FY2019 expiring lines following NIH oalm communication 24-16 (20231204) -$3,464
Original award $18,262

About this award

The National Cancer Institute awarded a Blanket Purchase Agreement (BPA) call valued at $14,798.54 to Bsrep II MBN LLC, doing business as the Bethesda North Marriott Hotel & Conference Center, for conference and lodging services associated with a scientific review board meeting (ZCA1 SRB-5) held June 6-7, 2019, at the Bethesda North Marriott Hotel & Conference Center in Rockville, Maryland. The contract was awarded on a firm fixed-price basis with no set-aside designation, and the hotel costs complied with Health and Human Services spending efficiency policies as of January 3, 2012. The ultimate completion date was established as March 25, 2024.

Bsrep II MBN LLC is a subsidiary of Marriott International specializing in providing hospitality services to federal agencies, with an extensive contracting history supporting National Institutes of Health scientific peer review meetings and conferences. The company has been registered in the System for Award Management since February 2005 and regularly provides facilities, lodging, meeting rooms, and audiovisual support for grant review panels and agency events across multiple NIH institutes and centers. This contract represents a typical engagement under the company's established relationship with the National Cancer Institute and other federal health agencies for mission-critical scientific review activities.

Quick answers

Who was awarded contract 75N91019F00136?

75N91019F00136 was awarded to Bsrep II MBN LLC by National Cancer Institute (National Institutes of Health) on June 6, 2019.

How much is contract 75N91019F00136 worth?

The government has obligated $14,799 on 75N91019F00136.

Is contract 75N91019F00136 an order under another contract?

Yes. 75N91019F00136 is a BPA call under HHSN263201500186B, a blanket purchase agreement.

Was contract 75N91019F00136 competed?

The extent of competition for 75N91019F00136 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award